Pentadecapeptide BPC-157 137525-51-0

90% up by HPLC

99% up by HPLC

Purity 99% up by HPLC, High Density

Product Information Product name Fusidic acid; Fusidine CAS No. 6990-06-3 Molecular Formula C31H48O6 Molecular Weight 516.719 Quality Standard 97.5% up by HPLC Appearance White or almost white, crystalline powder COA ANALYSIS SPECIFICATION RESULTS Appearance White or almost white, crystalline powder White crystalline powder Solubility Practically insoluble in water, freely soluble in ethanol (96%) Practically insoluble in water, freely soluble in ethanol (96%) Identification IR: IR absorption spectrum of sample is in identical with that of reference substance IR absorption spectrum of sample is in identical with that of reference substance Reaction of sodium:  The residue does not give reaction (a) of sodium The residue does not give reaction (a) of sodium Water 1.4%-2.0% 1.7% Sulfated ash ≤0.2% 0.1% Assay (on anhydrous basis) 97.5% - 101.0% 99.9% Particle size 90% Particle diamite < 20 μm 100% Particle diamite < 20 μm Related substance Impurity M ≤ 1.0% 0.1% Impurity G ≤ 0.7% Not detected Impurity L ≤ 0.5% Not detected Impurity B ≤ 0.4% Not detected Impurity A ≤ 0.3% Not detected Impurity H ≤ 0.10% Not detected Impurity C ≤ 0.2% Not detected Impurity D ≤ 0.2% Not detected Impurity F ≤ 0.2% Not detected Impurity I  ≤ 0.2% Not detected Impurity K ≤ 0.2% Not detected Impurity K ≤ 0.2% Not detected Max unknown impurity ≤ 0.10% Not detected Total impurities ≤ 2.0% 0.1% Residual solvents Ethanol ≤ 5000pm Not detected Methanol ≤ 3000pm Not detected Ethyl acetate ≤ 5000pm Not detected N-hexane ≤ 290pm Not detected Microbial limit Bacteria ≤ 100cfu/g Not detected Total molds and yeasts ≤ 10cfu/g Not detected Staphylococcus aureus: None Not detected Pseudomonas aeruginosa: None Not detected Conclusion The sample complies with EP. Usage The application of Fusidic acid: Fusidic acid is primarily used as an antibiotic to treat bacterial infections. It is commonly applied topically, as a Fusidic acid cream or Fusidic acid ointment, to treat skin infections such as impetigo, infected cuts or wounds, and infected eczema. In some cases, it may also be prescribed orally or intravenously to treat systemic infections, particularly those caused by Staphylococcus aureus, including methicillin-resistant Staphylococcus aureus (MRSA). Additionally, fusidic acid has been used in combination with other medications for the treatment of various infections. For example, it may be combined with corticosteroids to treat inflammatory skin conditions or with hydrocortisone to treat otitis externa (outer ear infections). Fusidic acid works by inhibiting bacterial protein synthesis, specifically targeting the ribosomes within bacterial cells. This mechanism of action makes it effective against a wide range of bacteria, particularly Staphylococcus species. However, it is important to use fusidic acid judiciously to prevent the development of antibiotic resistance. *Products under the patent are only for R&D use

99% up by HPLC, any impurities < 0.05%

99% up by HPLC

Product Information   Product name Pygeum Africanum Bark Extract Botanic source Pygeum Africana L. Active Ingredient Total phytosterols Part plant used 4:1, 10:1, 2.5%, 12.5% total phytosterols Quality Standard 98%, 90%, 50%. Or customized according to customer's request Appearance Light brown fine powder   COA of Pygeum Africanum Bark Extract   Item Specification Result Method Appearance Brown fine powder Complies Visual Odor Characteristic Complies Organoleptic Taste Characteristic Complies Organoleptic Drying Method Vacuum drying Complies / Loss on Drying ≤10.0% 4.30% TQ-104(105°C/2h) Ash (Sulphated Ash) ≤10.0% 5.56% TQ-104(525°C/3h) Particle Size NLT 100% Through 80 mesh Complies AOAC973.03(TQ_106) Total Heavy Metals ≤10ppm Complies ICP/MS AOAC 993.14 Lead(Pb) ≤1ppm Complies ICP/MS AOAC 993.14 Arsenic(As) ≤1ppm Complies ICP/MS AOAC 993.14 Cadmium (Cd) ≤1ppm Complies ICP/MS AOAC 993.14 Mercury(Hg) ≤0.05ppm Complies ICP/MS AOAC 993.14 Total Plate Count ≤10,000cfu/g 5000cfu/g AOAC996. 23 Total Yeast & Mold ≤1,000cfu/g 100cfu/g (BAM) 7th Ed. E.Coli Negative Negative USP33,NF28,2010 Salmonella Negative Negative USP33,NF28,2010 Staphylococcus Negative Negative USP33,NF28,2010 Conclusion The product meet the testing requirements   Usage   Pygeum africanum is a large evergreen tree found in central and southern Africa. The extracts from the pygeum bark contain several compounds thought to be helpful in prostate health.Pygeum extracts have been used for more than 40 years in France, Germany, and Austria for patients suffering with prostate enlargement. Benign prostatic hyperplasia,a nonmalignant enlargement of the prostate that occurs in most men over 60, can lead to urinary frequency and nocturia. Frequent interruption of sleep leads to daytime tiredness.   Function of Pygeum Africanum extract 1.Pygeum Africanum extract can inhibite benign prostatic hypertrophy and cancer of the prostate. 2.Pygeum bark extract can protecte the bladder smooth muscle against cellular damage caused by ischemia and reperfusion. 3.Pygeum Africanum extract can restore secretory activity of prostate epithelium. 4.Pygeum Africanum extract powder can clear bladder neck urethral obstruction, significantly improving urologic symptoms and flow measures. 5.Pygeum Africanum extract can be used for incontinence, urine retention, polyuria or frequent urination, dysuria.

98% up by HPLC, DMF, WC